MASI · As filed with the SEC
Masimo cash flow statement, by fiscal year
The statement as Masimo presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | FY2025 Year ended Jan 3, 2026 | FY2024 Year ended Dec 28, 2024 | FY2023 Year ended Dec 30, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net income | — | — | — | 143,500,000 |
| Net (loss) income | (151,500,000) | (304,900,000) | 81,500,000 | — |
| Loss from discontinued operations, net of tax | (359,200,000) | — | — | — |
| Net income from continuing operations, net of tax | 207,700,000 | — | — | — |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||
| Depreciation and amortization | 38,800,000 | 103,000,000 | 98,300,000 | 136,100,000 |
| Stock-based compensation | 35,800,000 | 41,500,000 | 7,000,000 | 47,700,000 |
| Amortization of debt issuance costs | 3,000,000 | 1,900,000 | 1,900,000 | 1,400,000 |
| Loss on disposal of inventory, equipment and other assets | 7,000,000 | 98,700,000 | 800,000 | 500,000 |
| Provision for credit losses | 3,000,000 | 1,100,000 | 1,100,000 | 1,300,000 |
| Benefit from deferred income taxes | 11,800,000 | (38,200,000) | (35,600,000) | (39,300,000) |
| Impairment charges, including intangible assets and goodwill - (Note 9 and Note 10) | — | 304,000,000 | 10,000,000 | — |
| Changes in operating assets and liabilities: | ||||
| (Increase) decrease in trade accounts receivable | 2,200,000 | (65,000,000) | 90,200,000 | (138,500,000) |
| (Increase) decrease in related party receivable | (700,000) | (7,900,000) | — | — |
| (Increase) decrease in inventories | (112,100,000) | (7,500,000) | (69,200,000) | (155,900,000) |
| (Increase) decrease in other current assets | 11,500,000 | 6,600,000 | (8,600,000) | (7,400,000) |
| (Increase) decrease in lease receivable, net | 15,700,000 | 12,700,000 | 1,700,000 | (12,800,000) |
| (Increase) decrease in deferred costs and other contract assets | (2,500,000) | (4,000,000) | (14,400,000) | (13,400,000) |
| (Increase) decrease in other non-current assets | 5,500,000 | (2,300,000) | 3,000,000 | (4,900,000) |
| Increase (decrease) in accounts payable | (27,100,000) | 14,800,000 | (19,600,000) | 60,500,000 |
| Increase (decrease) in accrued compensation | 12,200,000 | 22,200,000 | (26,800,000) | (9,300,000) |
| Increase (decrease) in deferred revenue and other contract-related liabilities | 3,700,000 | 10,300,000 | 7,100,000 | 28,100,000 |
| Increase (decrease) in income taxes payable | 3,900,000 | 2,200,000 | (15,100,000) | 3,800,000 |
| Increase (decrease) in accrued liabilities | (7,300,000) | 17,700,000 | (22,800,000) | (16,100,000) |
| Increase (decrease) in other non-current liabilities | 5,100,000 | (10,500,000) | 3,600,000 | 4,100,000 |
| Net cash provided by (used in) operating activities from continuing operations | 217,200,000 | — | — | — |
| Net cash provided by (used in) operating activities from discontinued operations | 600,000 | — | — | — |
| Net cash provided by (used in) operating activities | 217,800,000 | 196,400,000 | 94,100,000 | 29,400,000 |
| Cash flows from investing activities: | ||||
| Maturities of short-term investments | — | — | — | 0 |
| Purchases of property and equipment | (19,400,000) | (20,000,000) | (44,000,000) | (52,800,000) |
| Proceeds from the disposal of property and equipment | 19,600,000 | — | — | — |
| Increase in intangible assets | (5,300,000) | (31,100,000) | (43,700,000) | (3,500,000) |
| Business combinations, net of cash acquired | — | 0 | 7,500,000 | (999,700,000) |
| Deposit to acquire noncontrolling interest | — | — | — | 0 |
| Other strategic investing activities | — | — | — | (1,700,000) |
| Other strategic investing activities | — | (100,000) | (1,000,000) | — |
| Other strategic investing activities | 1,700,000 | — | — | — |
| Net cash provided by (used in) investing activities from continuing operations | (3,400,000) | — | — | — |
| Net cash provided by (used in) investing activities from discontinued operations | 278,500,000 | — | — | — |
| Net cash provided by (used in) investing activities | 275,100,000 | (51,200,000) | (81,200,000) | (1,057,700,000) |
| Cash flows from financing activities: | ||||
| Borrowings under revolving line of credit and term loan | 1,077,400,000 | 98,800,000 | 189,000,000 | 1,083,900,000 |
| Repayments under revolving line of credit and term loan | (1,281,500,000) | (237,800,000) | (240,200,000) | (135,400,000) |
| Proceeds from issuance of common stock | 71,400,000 | 25,200,000 | 7,000,000 | 8,100,000 |
| Repurchases of common stock | (363,700,000) | 0 | 0 | (401,500,000) |
| Payroll tax withholdings on behalf of employees for stock options | (18,000,000) | (11,800,000) | (12,900,000) | (25,400,000) |
| Debt issuance costs | (3,700,000) | 0 | 0 | (9,300,000) |
| Net cash provided by (used in) financing activities from continuing operations | (518,100,000) | — | — | — |
| Net cash provided by (used in) financing activities from discontinued operations | (2,600,000) | — | — | — |
| Net cash provided by (used in) financing activities | (520,700,000) | (125,600,000) | (57,100,000) | 520,400,000 |
| Effect of foreign currency exchange rates on cash | (300,000) | (6,400,000) | 2,800,000 | (30,900,000) |
| Net increase in cash, cash equivalents and restricted cash | (28,100,000) | 13,200,000 | (41,400,000) | (538,800,000) |
| Cash, cash equivalents and restricted cash at beginning of period | 181,400,000 | 168,200,000 | 209,600,000 | 748,400,000 |
| Cash, cash equivalents and restricted cash at end of period | 153,300,000 | 181,400,000 | 168,200,000 | 209,600,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.